SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-000740
Filing Date
2024-02-05
Accepted
2024-02-05 08:09:45
Documents
18
Period of Report
2024-02-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20240205x8k.htm   iXBRL 8-K 45643
2 EX-10.1 chrs-20240205xex10d1.htm EX-10.1 107655
3 EX-99.1 chrs-20240205xex99d1.htm EX-99.1 15505
4 GRAPHIC chrs-20240205xex99d1001.jpg GRAPHIC 6713
  Complete submission text file 0001558370-24-000740.txt   324985

Data Files

Seq Description Document Type Size
5 EX-101.SCH chrs-20240205.xsd EX-101.SCH 4157
6 EX-101.DEF chrs-20240205_def.xml EX-101.DEF 3158
7 EX-101.LAB chrs-20240205_lab.xml EX-101.LAB 15907
8 EX-101.PRE chrs-20240205_pre.xml EX-101.PRE 10735
19 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20240205x8k_htm.xml XML 4855
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 24594004
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)